Millennium Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Millennium Management’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-41,200	Closed	-$37K	–	7373
2021 Q1	$37K	Hold	41,200	–	–	﹤0.01%	5794
2020 Q4	$1.49M	Buy	+41,200	New	+$1.49M	﹤0.01%	3457

Other funds holding EVFM

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Millennium Management's EVFM Position: Q3 2022 in Review

Millennium Management sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2022, closing a stake of 37,160 shares — an estimated $42K sold.

Millennium Management first reported a position in EVFM in Q4 2014 and held it in 18 quarters. The position peaked at $5.03M in Q2 2020. 8 funds tracked by Wall St. Rank hold EVFM as of Q3 2022.

Millennium Management reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Millennium Management sold 37,160 Evofem Biosciences, Inc. Common Stock shares in Q3 2022, an estimated $42K.
Millennium Management first reported a position in Evofem Biosciences, Inc. Common Stock in Q4 2014 and held it in 18 quarters.
Millennium Management's Evofem Biosciences, Inc. Common Stock position peaked at $5.03M in Q2 2020.
8 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2022.

Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.